Glowing dye lights up cancer cells to help surgeons remove them

NCT ID NCT06819228

First seen Oct 31, 2025 · Last updated May 11, 2026 · Updated 19 times

Summary

This early-phase study tests a fluorescent dye attached to the cancer drug panitumumab to make head and neck cancer cells glow during surgery. About 18 adults with head and neck cancer who are already scheduled for surgery will receive the dye infusion before their operation. The main goal is to find the best dose that makes tumors glow brightest, helping surgeons see and remove cancer more precisely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HNSCC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.